#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arteriosclerosis Myocarditis Cognitive disorder Inclusion body myositis Extra-osseous Ewing's sarcoma T-cell type acute leukaemia Retinitis pigmentosa Brain abscess Monogenic diabetes Paraneoplastic neurological syndrome Liposarcoma metastatic Optic ischaemic neuropathy Acute myeloid leukaemia (in remission) Fabry's disease Ovarian cancer More trials…

    Learn about Rare Diseases

    Propionic acidaemia Haemophilia A with anti factor VIII – Trials in Disease Antithrombin III deficiency – Basic Information Alveolar rhabdomyosarcoma Usher’s syndrome – Treatment Nephrotic syndrome – Diagnostics Antithrombin III deficiency – Trials in Disease Friedreich’s ataxia – Life with Disease Tuberous sclerosis complex – Trials in Disease Leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivabradine Hydrochloride Adalimumab Azd8421 CHONDROITIN SULFATE SODIUM Dmd06-Mab Surzebiclimab Amivantamab Levofloxacin Clofutriben Aluminium ZIGAKIBART Pimozide Gsk4004280 Vosoritide Linvoseltamab Mexiletine Hydrochloride Gindameran S227928 Zilovertamab Vedotin Ceftriaxone More therapies…

    Learn about Your Condition

    Thyroid mass Venous thrombosis limb Eye disorder Ovarian cancer recurrent Transient ischaemic attack Intracranial aneurysm Vulvovaginal dryness Diabetic gastroparesis Hypothyroidism Cerebral haemorrhage Retinopathy proliferative Ovarian cancer stage III Altered state of consciousness Meningorrhagia Glomerulonephritis membranous More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Università degli studi Gabriele D’Annunzio Chieti-Pescara…

Università degli studi Gabriele D’Annunzio Chieti-Pescara Centro di Studi e tecnologie avanzate

Via Luigi Polacchi 11, Chieti, 66100, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of psilocybin compared to personalized rTMS treatment in adults with treatment-resistant depression

    Recruiting

    2 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Italy

  • Study on the Safety and Effectiveness of PolyCore (Xylitol, L-Carnitine, Polydextrin) for Patients with End-Stage Kidney Disease Starting Peritoneal Dialysis

    Recruiting

    2 1 1
    Investigated Diseases:
    • End stage renal disease
    Investigated Drugs:
    • Lactic Acid
    • Polydextrose
    • Levocarnitine
    Italy

  • Study on the Safety and Effectiveness of NEU-411 for Patients with Early Parkinson’s Disease

    Recruiting

    2 1
    Italy Poland Spain

  • Study on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events

    Recruiting

    3 1 1
    Investigated Drugs:
    • Carbasalate Calcium
    • Colchicine
    Denmark Finland France Greece Italy Portugal

  • Study on Low-Dose Colchicine for Patients with Peripheral Artery Disease to Reduce Cardiovascular Risks

    Recruiting

    3 1 1
    Investigated Drugs:
    • Colchicine
    Belgium Germany Italy The Netherlands

  • Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia Denmark Finland +12

  • Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Relapsing multiple sclerosis
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Anhydrous Cholestyramine
    • Magnetic Resonance Imaging Contrast Media
    • Teriflunomide
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study on Peritoneal Ultrafiltration with PolyCore for Patients with Congestive Heart Failure Using Levocarnitine and Drug Combination

    Recruiting

    4 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    Investigated Drugs:
    • Lactic Acid
    • Polydextrose
    • Levocarnitine
    Italy

  • Study on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Glucose Monohydrate Ph. Eur.
    • Levocarnitine
    • Sodium S-Lactate Solution
    Denmark Germany Italy Spain Sweden

  • Study on the Safety and Effectiveness of Methylprednisolone Sodium Succinate and Sodium Chloride for Patients with Severe Cardiac Inflammation

    Recruiting

    3 1 1
    Investigated Drugs:
    • Methylprednisolone Sodium Succinate
    • Sodium Chloride
    Austria Belgium Czechia Finland Italy Slovenia +2
Previous Page
1 2 3 4 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!